OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of $819.28 million. The enterprise value is $895.67 million.
Important Dates
The last earnings date was Tuesday, April 28, 2026, after market close.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OPKO Health has 755.09 million shares outstanding. The number of shares has increased by 12.81% in one year.
| Current Share Class | 755.09M |
| Shares Outstanding | 755.09M |
| Shares Change (YoY) | +12.81% |
| Shares Change (QoQ) | -0.87% |
| Owned by Insiders (%) | 42.67% |
| Owned by Institutions (%) | 25.02% |
| Float | 332.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.43 |
| Forward PS | 1.50 |
| PB Ratio | 0.69 |
| P/TBV Ratio | 26.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.61, with a Debt / Equity ratio of 0.33.
| Current Ratio | 3.61 |
| Quick Ratio | 2.83 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.95 |
Financial Efficiency
Return on equity (ROE) is -16.92% and return on invested capital (ROIC) is -15.79%.
| Return on Equity (ROE) | -16.92% |
| Return on Assets (ROA) | -6.36% |
| Return on Invested Capital (ROIC) | -15.79% |
| Return on Capital Employed (ROCE) | -11.87% |
| Weighted Average Cost of Capital (WACC) | 14.83% |
| Revenue Per Employee | $255,439 |
| Profits Per Employee | -$93,589 |
| Employee Count | 2,275 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 7.70 |
Taxes
| Income Tax | -16.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.38% in the last 52 weeks. The beta is 1.41, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | -15.38% |
| 50-Day Moving Average | 1.16 |
| 200-Day Moving Average | 1.30 |
| Relative Strength Index (RSI) | 40.06 |
| Average Volume (20 Days) | 2,213,460 |
Short Selling Information
The latest short interest is 33.76 million, so 4.47% of the outstanding shares have been sold short.
| Short Interest | 33.76M |
| Short Previous Month | 32.98M |
| Short % of Shares Out | 4.47% |
| Short % of Float | 10.14% |
| Short Ratio (days to cover) | 14.51 |
Income Statement
In the last 12 months, OPKO Health had revenue of $581.12 million and -$212.92 million in losses. Loss per share was -$0.28.
| Revenue | 581.12M |
| Gross Profit | 86.68M |
| Operating Income | -202.83M |
| Pretax Income | -228.97M |
| Net Income | -212.92M |
| EBITDA | -112.49M |
| EBIT | -202.83M |
| Loss Per Share | -$0.28 |
Full Income StatementBalance Sheet
The company has $331.86 million in cash and $396.93 million in debt, with a net cash position of -$65.07 million or -$0.09 per share.
| Cash & Cash Equivalents | 331.86M |
| Total Debt | 396.93M |
| Net Cash | -65.07M |
| Net Cash Per Share | -$0.09 |
| Equity (Book Value) | 1.20B |
| Book Value Per Share | 1.60 |
| Working Capital | 386.98M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$163.30 million and capital expenditures -$10.92 million, giving a free cash flow of -$174.22 million.
| Operating Cash Flow | -163.30M |
| Capital Expenditures | -10.92M |
| Depreciation & Amortization | 90.34M |
| Net Borrowing | -67.04M |
| Free Cash Flow | -174.22M |
| FCF Per Share | -$0.23 |
Full Cash Flow StatementMargins
Gross margin is 14.92%, with operating and profit margins of -34.90% and -36.64%.
| Gross Margin | 14.92% |
| Operating Margin | -34.90% |
| Pretax Margin | -39.40% |
| Profit Margin | -36.64% |
| EBITDA Margin | -19.36% |
| EBIT Margin | -34.90% |
| FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.81% |
| Shareholder Yield | -12.81% |
| Earnings Yield | -25.63% |
| FCF Yield | -20.97% |
Analyst Forecast
The average price target for OPKO Health is $1.60, which is 47.47% higher than the current price. The consensus rating is "Hold".
| Price Target | $1.60 |
| Price Target Difference | 47.47% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 2.75% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.61 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.61 |
| Piotroski F-Score | 2 |
